The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

BioMarin Pharmaceutical (NASDAQ:BMRN) executives used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to ...

Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as 'Ascentage Pharma,” the 'Company,” 'we,” 'us” or 'our”), a global, commercial stage, integrated ...

Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events -- Topline data readout ...

WASHINGTON — Activists are urging Maryland lawmakers to prohibit drug corporations from writing off advertisements as business expenses, an act that they say would funnel millions of dollars to the ...

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

Citi Pharma Limited, one of Pakistan’s leading pharmaceutical companies, has approved the launch of an initial public offering (IPO) for its wholly owned subsidiary, Citi Veterinary Pharma Limited.

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

Consolidated revenue of €4.1 million at the end of December 2025 Cash position of €3.5 million as of December 31, 2025 Cash runway through year-end 2026 excluding France 2030 non-dilutive ...

Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio optimization for biotech investors and pharmaceutical ...